370 related articles for article (PubMed ID: 28709776)
21. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Ennis ZN; Damkier P
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):315-20. PubMed ID: 25536446
[TBL] [Abstract][Full Text] [Related]
24. Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.
Kishi T; Moriwaki M; Kitajima T; Kawashima K; Okochi T; Fukuo Y; Furukawa O; Naitoh H; Fujita K; Iwata N
Psychopharmacology (Berl); 2010 Apr; 209(2):185-90. PubMed ID: 20177883
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.
Poulos J; Normand ST; Zelevinsky K; Newcomer JW; Agniel D; Abing HK; Horvitz-Lennon M
Psychol Med; 2023 Dec; 53(16):7677-7684. PubMed ID: 37753625
[TBL] [Abstract][Full Text] [Related]
26. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
27. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
28. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Alda JA; Muñoz-Samons D; Tor J; Merchán-Naranjo J; Tapia-Casellas C; Baeza I; Calvo-Escalona R; Castro-Fornieles J; Martínez-Cantarero C; Andrés-Nestares P; Fernández-Avilés F; Arango C
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):449-57. PubMed ID: 26779966
[TBL] [Abstract][Full Text] [Related]
29. Autonomic nervous system activity and psychiatric severity in schizophrenia.
Fujibayashi M; Matsumoto T; Kishida I; Kimura T; Ishii C; Ishii N; Moritani T
Psychiatry Clin Neurosci; 2009 Aug; 63(4):538-45. PubMed ID: 19496998
[TBL] [Abstract][Full Text] [Related]
30. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Kinon BJ; Liu-Seifert H; Adams DH; Citrome L
J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW
J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420
[TBL] [Abstract][Full Text] [Related]
32. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
Am J Geriatr Psychiatry; 2005 May; 13(5):377-84. PubMed ID: 15879586
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
Hatta K; Sato K; Hamakawa H; Takebayashi H; Kimura N; Ochi S; Sudo Y; Asukai N; Nakamura H; Usui C; Kawabata T; Hirata T; Sawa Y
Schizophr Res; 2009 Aug; 113(1):49-55. PubMed ID: 19553086
[TBL] [Abstract][Full Text] [Related]
34. Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Noguchi N; Furuno T; Asami T; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Saeki T; Fukushima T; Moritani T; Saigusa Y; Hishimoto A
BMC Psychiatry; 2023 Mar; 23(1):135. PubMed ID: 36869320
[TBL] [Abstract][Full Text] [Related]
35. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia.
Iwamoto Y; Kawanishi C; Kishida I; Furuno T; Fujibayashi M; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2012 Nov; 12():199. PubMed ID: 23151241
[TBL] [Abstract][Full Text] [Related]
37. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Lee SY; Park MH; Patkar AA; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Remmerie B; De Meulder M; Ariyawansa J; Savitz A
Clin Pharmacol Drug Dev; 2016 Nov; 5(6):538-547. PubMed ID: 27363344
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
Ono S; Sugai T; Suzuki Y; Yamazaki M; Shimoda K; Mori T; Ozeki Y; Matsuda H; Sugawara N; Yasui-Furukori N; Okamoto K; Sagae T; Someya T
BMC Psychiatry; 2018 Jun; 18(1):180. PubMed ID: 29879941
[TBL] [Abstract][Full Text] [Related]
40. Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.
Zhang L; Li YG; He S; Zhang Y; Yu YM; Li Y; Wen H; Qiao Y; Shen YF; Li HF
Acta Pharmacol Sin; 2019 Dec; 40(12):1611-1620. PubMed ID: 31388088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
